150 related articles for article (PubMed ID: 20848421)
1. Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: a meta-analysis.
Xu GZ; Zhu XD; Li MY
Head Neck; 2011 Jan; 33(1):87-94. PubMed ID: 20848421
[TBL] [Abstract][Full Text] [Related]
2. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
Xu GZ; Guan DJ; He ZY
Oral Oncol; 2011 Jul; 47(7):560-5. PubMed ID: 21621450
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.
Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH
Eur J Radiol; 2013 Feb; 82(2):366-73. PubMed ID: 23083522
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
[TBL] [Abstract][Full Text] [Related]
5. Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis.
Xu G; Li J; Zuo X; Li C
Laryngoscope; 2012 Sep; 122(9):1974-8. PubMed ID: 22753007
[TBL] [Abstract][Full Text] [Related]
6. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
7. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
8. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
9. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system.
Sekine T; de Galiza Barbosa F; Kuhn FP; Burger IA; Stolzmann P; Huber GF; Kollias SS; von Schulthess GK; Veit-Haibach P; Huellner MW
Clin Imaging; 2017; 42():232-239. PubMed ID: 28129606
[TBL] [Abstract][Full Text] [Related]
10. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K
Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP
J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804
[TBL] [Abstract][Full Text] [Related]
12. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
13. What does PET imaging add to conventional staging of head and neck cancer patients?
Pohar S; Brown R; Newman N; Koniarczyk M; Hsu J; Feiglin D
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):383-7. PubMed ID: 17379443
[TBL] [Abstract][Full Text] [Related]
14. Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Coleman RE
Radiology; 2007 Jul; 244(1):263-72. PubMed ID: 17495174
[TBL] [Abstract][Full Text] [Related]
15. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
16. Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy.
Ishikita T; Oriuchi N; Higuchi T; Miyashita G; Arisaka Y; Paudyal B; Paudyal P; Hanaoka H; Miyakubo M; Nakasone Y; Negishi A; Yokoo S; Endo K
Ann Nucl Med; 2010 Feb; 24(2):77-82. PubMed ID: 20058105
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
18. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
19. Performance of whole-body PET/CT for the detection of distant malignancies in various cancers: a systematic review and meta-analysis.
Xu G; Zhao L; He Z
J Nucl Med; 2012 Dec; 53(12):1847-54. PubMed ID: 23073605
[TBL] [Abstract][Full Text] [Related]
20. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Gao S; Li S; Yang X; Tang Q
Oral Oncol; 2014 Mar; 50(3):163-7. PubMed ID: 24368204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]